Published 1 September 2026 · Reviewed by Dr Sin Yong
You had laser to clear pigment, and the pigment came back darker. It feels like betrayal, and the instinct is to blame the machine or yourself. Usually neither is the culprit. Rebound pigmentation has understandable mechanisms — and the response to it is the opposite of the instinct to push harder.
The logic seems airtight: if some energy faded the pigment a little, more energy should fade it more. It is the same logic as scrubbing a stain harder, and on skin it fails for a specific reason — the treatment itself is an injury, and injured skin makes pigment.
Every laser pulse deposits energy, and in melanin-rich skin much of that energy is intercepted by the epidermis on its way in. Push the settings up and you are not just hitting the target pigment harder; you are heating the surrounding skin harder, inflaming it more, and handing its melanocytes a stronger instruction to produce. The result arrives on a delay — the skin often looks cleaner immediately after treatment, then darkens over the following weeks as the inflammatory pigment is manufactured and delivered.
That delay is what makes the trap so effective. The immediate feedback says the aggressive setting worked; the rebound arrives weeks later, after the decision has already been reinforced — and by then it is easy to blame the wrong thing. In pigment work, restraint is not timidity. It is the mechanism-literate position, and it is the one that keeps darker skin out of trouble.
“Turning the energy up feels like progress. In melasma it is often how rebound starts.”
Dr Sin YongOn aggressive settings in pigment work
Post-inflammatory hyperpigmentation is exactly what its name says: pigment produced by melanocytes as part of the skin’s response to inflammation. Acne does it, injuries do it, and treatments do it — any insult vigorous enough to inflame the skin can leave a brown shadow where the inflammation was.
Skin type sets the stakes. In Fitzpatrick III to V skin — which describes most patients in Singapore — melanocytes are more reactive, and the PIH response is both more likely and more persistent than in lighter skin. The same setting that a fair-skinned patient tolerates uneventfully can leave a darker-skinned patient with weeks or months of new pigment. This is why settings are chosen for the skin in front of the machine, not copied from a manufacturer’s default or another clinic’s protocol.
Depth matters too. Pigment can sit in the epidermis, in the dermis, or in both, and each layer answers to different wavelengths. Energy aimed at the wrong depth inflames the skin without clearing the target — the worst possible exchange, since you collect the PIH risk and none of the benefit. Establishing where the pigment lives is part of diagnosis, not a detail.
The severest rebounds I see share a storyline: the pigment was melasma, and it was treated as if it were sun spots. Melasma is a chronic condition driven by hormonal, ultraviolet and vascular factors — and it is heat-sensitive. Thermal stimulus is itself a trigger. Aggressive laser work therefore does two harmful things at once: it inflames the skin, inviting PIH, and it feeds the underlying condition with the very stimulus it responds to.
This is why distinguishing melasma from lentigines before treatment is not academic. The two conditions look similar and are treated almost oppositely — a distinction I set out fully in melasma versus sun spots. A sharply bordered spot that tolerates decisive energy and a soft-edged, symmetrical patch that punishes it can sit on the same cheek.
Where laser is used in melasma at all, it is used conservatively: typically low-fluence 1064 nm, a deeper-penetrating wavelength at gentle energies that spares the melanin-rich epidermis, positioned as one component of melasma management built on photoprotection and topical therapy. Fractional and pigment-specific platforms, including the picosecond systems used in protocols like T2 Frax Radiance, have their place — but the place is decided by diagnosis and skin type, never by enthusiasm.
The first instruction is the hardest one: stop. No further energy into inflamed, darkening skin — not a rescue session, not a different machine, not a stronger peel. Rebound pigment is inflammatory in origin, and every additional insult extends the inflammation that is producing it. The skin needs the opposite: strict daily broad-spectrum sun protection, gentle care, and time for the inflammatory process to close.
The second instruction is reassessment, and it should be genuinely fresh rather than a louder repeat of the last plan. What was the pigment actually — lentigines, melasma, PIH, or a mixture? At what depth does it sit? What settings were used, and what does the skin’s reaction reveal about its reactivity? Rebound is unwelcome, but it is also information: it tells you something about the diagnosis or the parameters that was not known before.
Only then is treatment restaged — conservatively, in steps small enough to read the skin’s response before the next one. Response varies between individuals, and in darker skin the margin for error is narrower, which is precisely why the pace is slower. That is not a lesser plan. It is the plan that ends with less pigment rather than more.
If you are researching rebound pigmentation, you will have seen sites full of photo pairs, and their absence here deserves a direct explanation.
Under Singapore’s Healthcare Services Act, before-and-after imagery in advertising for licensable healthcare services is prohibited. No consent form or disclaimer creates an exemption, and after-only images fall under the same rule. This applies identically to every licensed clinic in Singapore — a site showing such images is not demonstrating better outcomes, only weaker compliance.
For rebound cases the honest substitute is an examination: your skin, in person, with an assessment of what the pigment now is and what a conservative restaging could involve.
Prices for licensable healthcare services cannot be advertised in Singapore, including as ranges or “from” figures. What can be set out is what the cost of managing rebound pigmentation depends on.
The factors are the area involved, what the reassessment finds the pigment to be and how deeply it sits, whether topical therapy alone is indicated for a period before any device is reintroduced, and how the plan is staged over time. A localised patch of settling PIH and provoked melasma across both cheeks are very different situations. Fees are set out in full at consultation, once there is a specific plan to cost.
Pigment that worsened after laser is not proof that lasers are dangerous or that your skin is untreatable. It is usually the fingerprint of a mismatch — between the diagnosis and the condition, or between the settings and the skin type. Both mismatches are correctable, but not by escalation.
The path back runs through patience: stop the insults, protect the skin from the sun that feeds every pigment process, re-diagnose properly, and restage at energies the skin can absorb without protest. I assess these cases personally at Orchard Road, and if the right prescription for the next few months is no laser at all, that is what you will be told.
The usual mechanism is post-inflammatory hyperpigmentation: the laser inflames the skin, and melanocytes respond to inflammation by producing pigment. It is more likely in Fitzpatrick III to V skin, where melanocytes are more reactive, and when settings were too aggressive for the skin type. If the underlying condition was melasma, the heat of treatment can also have driven the condition itself.
Post-inflammatory hyperpigmentation is generally a settling process rather than a fixed mark, though its course varies with skin type, depth and ongoing sun exposure, and it can persist for a long time in darker skin. The essentials are to stop further irritation, protect the skin from ultraviolet daily, and have the pigment reassessed so its actual nature is known. Response varies between individuals.
Stop all energy-based treatment and aggressive skincare on the area, use strict daily broad-spectrum sun protection, and keep the skin’s care gentle while the inflammation settles. Then arrange a reassessment of what the pigment actually is before anything further is done. Adding more treatment to inflamed, darkening skin extends the process that is producing the pigment.
No. Rebound pigment is inflammatory in origin, and stronger energy means stronger inflammation — the mechanism that created the problem. The corrective direction is the opposite: settle the skin, re-diagnose, and if a device is reintroduced at all, reintroduce it conservatively at settings chosen for your skin type. Escalation is how rebound cycles continue.
Fitzpatrick III to V skin carries more epidermal melanin and more reactive melanocytes. The melanin competes for incoming laser energy, so more heat is deposited in the surface layers, and the melanocytes respond to that inflammation more readily with pigment production. Neither point makes treatment impossible; both make conservative, skin-type-specific settings essential.
It is one of the commonest explanations. Melasma is heat-sensitive and chronic, so treatment aggressive enough to suit sun spots can provoke it into producing more pigment. Clues include soft-edged, roughly symmetrical patches on the cheeks, forehead or upper lip and a history of darkening with sun, heat or hormonal change. An in-person examination distinguishes melasma from post-inflammatory pigment and lentigines.
Until the inflammation has genuinely settled and the pigment has been re-diagnosed — a judgement made by examining the skin rather than by the calendar. The interval differs between individuals and depends on skin type, the depth of the pigment and how the skin reacted. Restaging begins conservatively, with each step read before the next is taken.
Risk is reduced, though never abolished, by correct diagnosis before treatment, wavelengths and energies chosen for the skin type, conservative staging with the skin’s response reviewed between steps, and disciplined sun protection throughout. In melanin-rich skin the settings that look unimpressive on paper are often the ones chosen deliberately, because restraint is what keeps inflammation — and therefore rebound — low.
Passeron T, Picardo M. Melasma, a photoaging disorder. Pigment Cell & Melanoma Research 2018;31(4):461–465. source
Rebound pigmentation is reassessed individually at Orchard Road, Singapore. Consultations by appointment.
WhatsApp +65 8023 7170 →